Category: CAR T-cell Therapy

Waldenström macroglobulinemia: What to Know in Practice

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN

CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Charting the Course of ALL: From Diagnosis to Advances

Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

CAR T-cell Therapy in 2024

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO

Scroll to Top